136607-29-9

Upstream product

• 700-13-0 Trimethylhydroquinone 
• 100-44-7 benzyl chloride 
• 100-39-0 benzyl bromide 

Downstream Products

• 1187314-29-9 2,5-bis(benzyloxy)-3,4,6-trimethylbenzaldehyde 
• 1187313-96-7 2-(2,5-bis(benzyloxy)-3,4,6-trimethylphenyl)ethanamine 
• 1202020-72-1 2,5-bis(benzyloxy)-(3,4,6-trimethyl)nitrostyrene 
• 1202020-69-6 2,3,5-trimethyl-6-(2-(4-(trifluoromethyl)pyridin-2-ylamino)ethyl)cyclohexa-2,5-diene-1,4-dione 

Relevant academic research and scientific papers

SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES

Methods of treating or suppressing oxidative stress diseases including mitochondrial diseases, impaired energy processing disorders, neurodegenerative diseases and diseases of aging are disclosed, as well as compounds useful in the methods of the invention, such as 2-substituted-p-quinone derivatives as disclosed herein.

RESORUFIN DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS

Disclosed herein are resorufin derivative compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging.

2-HETEROCYCLYLAMINOALKYL-(P-QUINONE) DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES

Methods of treating or suppressing oxidative stress disorders including mitochondrial diseases, impaired energy processing disorders, neurodegenerative diseases and diseases of aging are disclosed, as well as compounds useful in the methods of the invention, such as 2-heterocyclylaminoalkyl-(p-quinone) derivatives.